BillionToOne, Inc.
NASDAQ: BLLN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Oguzhan Atay
- Employees
- 620
- Headquarters
- Menlo Park, United States
- IPO year
- 2025
- Market cap
- $4.8B
- Website
- https://www.billiontoone.com
Loading BLLN…
Loading profile data…Frequently asked questions about BLLN
What does BillionToOne, Inc. (BLLN) do?
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the...
Where does BLLN trade?
BillionToOne, Inc. (BLLN) trades on the NASDAQ Global Select.
What sector is BLLN in?
BillionToOne, Inc. (BLLN) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BillionToOne, Inc.?
Oguzhan Atay is the chief executive officer of BillionToOne, Inc. (BLLN).
Where is BillionToOne, Inc. headquartered?
BillionToOne, Inc. is headquartered in United States.
Does BLLN pay a dividend?
BillionToOne, Inc. (BLLN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BLLN go public?
BillionToOne, Inc. (BLLN) completed its initial public offering in 2025.